...
首页> 外文期刊>Journal of AAPOS: The official publication of the American Association for Pediatric Ophthalmology and Strabismus >Exudative retinopathy and detachment: A late reactivation of retinopathy of prematurity after intravitreal bevacizumab
【24h】

Exudative retinopathy and detachment: A late reactivation of retinopathy of prematurity after intravitreal bevacizumab

机译:渗出性视网膜病变和脱离:玻璃体内贝伐单抗治疗后早熟性视网膜病变的再激活

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 25-week postmenstrual age premature infant was treated with bilateral intravitreal bevacizumab for retinopathy of prematurity at 35 weeks' PMA. Postinjection, the retinal vessels progressed anteriorly within the retina. The patient presented 1 year after injection with bilateral exudative retinal detachments. The right eye was treated with intravitreal bevacizumab, laser ablation, and scleral buckling, resulting in resolution of the exudation and detachment. The left eye was treated with vitrectomy and lensectomy, but persistent exudation and detachment remained. This case demonstrates the rare complication of exudative retinal detachment in the setting of retinopathy of prematurity, which may become more common with increasing use of bevacizumab. Importantly, it also demonstrates the need not only for frequent examination after bevacizumab injection for retinopathy of prematurity but long-term follow-up as well, until either the retina is fully vascularized or peripheral ablation is performed.
机译:于25周PMA时,对一个25周的早产儿进行双侧玻璃体内贝伐单抗治疗,以治疗早产儿视网膜病变。注射后,视网膜血管在视网膜内向前发展。该患者注射后1年出现双侧渗出性视网膜脱离。右眼接受玻璃体内贝伐单抗,激光消融和巩膜屈曲治疗,从而解决了渗出和脱离。左眼接受了玻璃体切除术和晶状体切除术治疗,但仍持续渗出和脱离。该病例表明,在早产儿视网膜病变的情况下,渗出性视网膜脱离的罕见并发症,随着贝伐单抗使用的增加,可能会变得更加普遍。重要的是,它还表明不仅需要在贝伐单抗注射后进行早产儿视网膜病变的频繁检查,而且还需要长期随访,直到视网膜完全血管化或进行周边消融为止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号